Pfizer Inc.
PFEFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
63,627
Cost of Revenue
21,781
Gross Profit
41,846
Gross Margin
65.8%
Operating Income
16,483
Operating Margin
25.9%
Net Income
8,020
Net Margin
12.6%
EPS (Basic)
$1.42
EPS (Diluted)
$1.41
EBITDA
18,127
EBITDA Margin
28.5%
2023
12/31/2023
Revenue
59,553
Cost of Revenue
29,213
Gross Profit
30,340
Gross Margin
50.9%
Operating Income
5,292
Operating Margin
8.9%
Net Income
2,133
Net Margin
3.6%
EPS (Basic)
$0.38
EPS (Diluted)
$0.37
EBITDA
9,557
EBITDA Margin
16.0%
2022
12/31/2022
Revenue
100,330
Cost of Revenue
38,240
Gross Profit
62,090
Gross Margin
61.9%
Operating Income
37,549
Operating Margin
37.4%
Net Income
31,365
Net Margin
31.3%
EPS (Basic)
$5.59
EPS (Diluted)
$5.47
EBITDA
41,031
EBITDA Margin
40.9%
2021
12/31/2021
Revenue
81,288
Cost of Revenue
34,413
Gross Profit
46,875
Gross Margin
57.7%
Operating Income
20,793
Operating Margin
25.6%
Net Income
22,147
Net Margin
27.2%
EPS (Basic)
$3.95
EPS (Diluted)
$3.88
EBITDA
30,793
EBITDA Margin
37.9%
2020
12/31/2020
Revenue
41,651
Cost of Revenue
11,771
Gross Profit
29,880
Gross Margin
71.7%
Operating Income
9,085
Operating Margin
21.8%
Net Income
9,159
Net Margin
22.0%
EPS (Basic)
$1.65
EPS (Diluted)
$1.63
EBITDA
13,168
EBITDA Margin
31.6%